BLCO vs TGTX

The Advanced Deterministic Scorecard reveals severe financial health concerns with a Piotroski F-Score of just 2/9, indicating weak operational and balance sheet performance. Despite a reasonable Price/Book of 0.94 and a Debt/Equity ratio of 0.76, the company is unprofitable with a negative ROE of -4.50% and a profit margin of -6.13%. Earnings have collapsed year-over-year (-147.1%) and the last four quarters missed estimates by an average of -154.31%, signaling deteriorating fundamentals. While revenue growth of 7.10% and a gross margin above 59% provide some operational strength, the persistent earnings deterioration and lack of profitability undermine valuation support.

TGTX exhibits a stable financial foundation with a Piotroski F-Score of 6/9 and exceptional profitability margins, yet it faces a significant valuation gap. The stock is trading at $36.96, which is nearly double its Graham Number ($16.79) and Intrinsic Value ($19.39). While revenue growth is explosive at 78%, the company has missed earnings estimates in four consecutive quarters with an average surprise of -41.54%, and YoY earnings growth has turned negative (-6.10%). The disconnect between strong top-line growth and failing bottom-line expectations creates a high-risk profile despite the 'Buy' analyst consensus.